<br> We conditionally recommend IV BP, ROM, RAL over no treatment in high and very high risk of fracture. <br> In moderate risk, we conditionally recommend BP, DEN, or PTH/PTHrP in no preferred order among these agents. <br> Except in patients intolerant of other agents, we conditionally recommend against RAL due to harms of VTE and fatal stroke or ROM due to uncertain harms with increased myocardial infarction, stroke and death. | We conditionally recommend treatment for those at moderate or